CN105481792A - Synthetic method with respect to pramipexole impurity C - Google Patents
Synthetic method with respect to pramipexole impurity C Download PDFInfo
- Publication number
- CN105481792A CN105481792A CN201410498904.1A CN201410498904A CN105481792A CN 105481792 A CN105481792 A CN 105481792A CN 201410498904 A CN201410498904 A CN 201410498904A CN 105481792 A CN105481792 A CN 105481792A
- Authority
- CN
- China
- Prior art keywords
- compound
- add
- synthetic method
- benzothiazole
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
Abstract
The invention discloses a synthetic method with respect to a pramipexole impurity C and belongs to the field of drug synthesis. The method comprises the steps of: by taking a compound I 2-amino-6-propionyl amine-4,5,6,7-tetrahydrobenzothiazole as a raw material, generating a compound II 6-nitrogen[2-amino-4,6-tetrahydro1,3-benzothiazole-6-yl]-1-ethyl-2-methyl-3- carbonyl propyl hydrocarbyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine under the action of sodium methylate, then performing a reaction on the compound II and dithioglycol to obtain a compound III 6-nitrogen[2-amino-4,6-tetrahydro1,3-benzothiazole-6-yl]-1-ethyl-2-methyl-3-ketone thioacetal propyl hydrocarbyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; and then by taking nickel as a catalyst, performing hydrogenation reduction to obtain a mixed isomer of a compound IV: (6S)-6-nitrogen[3-(6S)-2-amino-4,6-tetrahydro1,3-benzothiazole-6-yl]-1-ethyl-2-methyl propyl]-4,5,6,7-tetrahydro1,3-benzothiazole-2,6-diamine. The compound prepared by the method is relatively high in purity, and the method is simple to operate.
Description
Technical field
The present invention relates to the synthetic method of a kind of pramipexole impurity C.
Technical background
Pramipexole is used to the S&S for the treatment of idiopathic parkinsonism, and pramipexole is a kind of non-ergot class dopamine agonist.In vitro study shows, and the specificity of pramipexole to D2 acceptor is higher and have intrinsic activity completely, to the avidity of D3 acceptor higher than D2 and D4 acceptor.Pramipexole oral absorption is complete rapidly.
Mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4,6-tetrahydrochysene 1,3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4,5,6,7-tetrahydrochysene 1,3-benzothiazole-2,6-diamines is impurity contained in pramipexole finished product, does not also report its synthetic method in existing patent, document.
Summary of the invention
Introduction of the present invention be the synthetic method of a kind of impurity C of pramipexole
The synthetic route of pramipexole impurity C provided by the invention is as follows:
Compound I 2-amino-6-propionyl amine-4, 5, 6, 7-tetrahydro benzothiazol generates Compound II per 6-nitrogen [2-amino-4 under the effect of sodium methylate, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl-3-carbonyl third alkyl]-4, 5, 6, 7-tetrahydrochysene-1, 3-benzothiazole-2, 6-diamines, Compound II per reacts to obtain compound III 6-nitrogen [2-amino-4 again with dithioglycol, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl-3-contracting thioketones third alkyl]-4, 5, 6, 7-tetrahydrochysene-1, 3-benzothiazole-2, 6-diamines, compound III is that catalyst hydrogenation reduces and to obtain compound IV mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4 with nickel, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4, 5, 6, 7-tetrahydrochysene 1, 3-benzothiazole-2, 6-diamines.
Preferably, alkaline reagents used in step a is the one in sodium methylate, sodium ethylate, sodium hydroxide or potassium hydroxide.
Preferably, solvent used in step a is the one in methyl alcohol, ethanol or Virahol.
Preferably, the range of reaction temperature in step b is 0-50 DEG C.
Preferably, in step c, used catalyst is nickel, Raney's nickel, or the one in palladium charcoal.
Preferably, the range of reaction temperature in step c is 0-50 DEG C.
Preferably, the mol ratio of Compound I and alkali is 1:1.0-1.4.
Preferably, the mol ratio of Compound I and dithioglycol is 1:1.0-1.1.
Preferred version is, comprises the following steps:
A, Compound I 2-amino-6-propionyl amine-4,5,6,7-tetrahydro benzothiazol add in reaction flask, then add methyl alcohol, add sodium methylate under stirring, are heated to backflow, are then cooled to room temperature.
B, slowly drip dithioglycol, dropwise rear temperature control stirring and react 3 hours, then concentrating under reduced pressure solvent evaporated, add wherein methylene dichloride stir molten clear after, add purified water agitator treating, point water-yielding stratum, in methylene dichloride, add magnesium sulfate stir dry, filtering siccative, evaporated under reduced pressure methylene dichloride.
C, add dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to autoclave, add catalyzer, pressure 0.1mpa is kept with passing into hydrogen after nitrogen replacement, temperature control stirring reacts 3 hours, filtering reacting liquid, be evaporated to dry, add recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [amino-4, the 6-tetrahydrochysenes 1 of 3-(6S)-2-, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4,5,6,7-tetrahydrochysene 1,3-benzothiazole-2,6-diamines.
Embodiment
In order to understand the present invention better, illustrate content of the present invention further below in conjunction with embodiment, but content of the present invention is not only confined to the following examples, embodiment should not regard as limiting the scope of the present invention.
Below in conjunction with example, the present invention will be further described:
Implement 1
Get 50g Compound I 2-amino-6-propionyl amine-4, 5, 6, 7-tetrahydro benzothiazol adds in 500ml there-necked flask, then methyl alcohol 200ml is added, 14.4g sodium methylate is added under stirring, be heated to back flow reaction 2 hours, then room temperature is cooled to, slow dropping 22g dithioglycol, dropwise rear temperature control 25 DEG C of stirring reactions 3 hours, then water-bath 40 DEG C of concentrating under reduced pressure solvent evaporated, add wherein 200ml methylene dichloride stir molten clear after, add purified water 200ml agitator treating, divide water-yielding stratum, 200ml purified water is added again in methylene dichloride, agitator treating, divide water-yielding stratum, in methylene dichloride, add 5g magnesium sulfate stir dry 1 hour, filtering siccative, temperature control less than 40 DEG C evaporated under reduced pressure methylene dichloride, add 200ml dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to 500ml autoclave, add 65g nickel, pressure 0.1mpa is kept with passing into hydrogen after nitrogen replacement, temperature control 25 DEG C of stirring reactions 3 hours, filtering reacting liquid, be evaporated to dry, add 270ml recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4, 5, 6, 7-tetrahydrochysene 1, 3-benzothiazole-2, 6-diamines 29.0g, purity 98.2%, yield 61.0%.
Embodiment 2
Get 50g Compound I 2-amino-6-propionyl amine-4, 5, 6, 7-tetrahydro benzothiazol adds in 500ml there-necked flask, then ethanol 200ml is added, 18.2g sodium ethylate is added under stirring, be heated to back flow reaction 2 hours, then room temperature is cooled to, slow dropping 22g dithioglycol, dropwise rear temperature control 20 DEG C of stirring reactions 4 hours, then water-bath 40 DEG C of concentrating under reduced pressure solvent evaporated, add wherein 200ml methylene dichloride stir molten clear after, add purified water 200ml agitator treating, divide water-yielding stratum, 200ml purified water is added again in methylene dichloride, agitator treating, divide water-yielding stratum, in methylene dichloride, add 5g magnesium sulfate stir dry 1 hour, filtering siccative, temperature control 40 DEG C of evaporated under reduced pressure methylene dichloride, add 200ml dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to 500ml autoclave, add 65g nickel, pressure 0.2mpa is kept with passing into hydrogen after nitrogen replacement, temperature control 30 DEG C of stirring reactions 2 hours, filtering reacting liquid, be evaporated to dry, add 270ml recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4, 5, 6, 7-tetrahydrochysene 1, 3-benzothiazole-2, 6-diamines 28.1g, purity 98.4%, yield 59.2%.
The above is the preferred embodiment of the present invention; for the practical study technician of the art; under the premise without departing from the principles of the invention, can also make some improvements and modifications, these improvements and modifications are also regarded as protection scope of the present invention.
Claims (9)
1. the present invention relates to a kind of synthetic method of pramipexole impurity C, it is characterized in that, comprise the following steps:
A), Compound I reacting by heating in alkaline environment obtains chemical combination II;
B), Compound II per and dithioglycol react to obtain compound III;
C), compound III obtains compound IV by hydro-reduction.
2., in synthetic method according to claim 1, alkaline reagents used in step a is sodium methylate, sodium ethylate, sodium hydroxide or potassium hydroxide.
3., in synthetic method according to claim 1, solvent used in step a is methyl alcohol, ethanol or Virahol.
4., in synthetic method according to claim 1, the range of reaction temperature in step b is 0-50 DEG C.
5., in synthetic method according to claim 1, in step c, used catalyst is nickel, Raney's nickel or palladium charcoal.
6., in synthetic method according to claim 1, the range of reaction temperature in step c is 0-50 DEG C.
7., in synthetic method according to claim 1, the mol ratio of Compound I and alkali is 1:1.0-1.4.
8., in synthetic method according to claim 1, the mol ratio of Compound I and dithioglycol is 1:1.0-1.1.
9., according to the synthetic method of the arbitrary described pramipexole impurity C of claim 1-8, it is characterized in that, comprise the following steps:
A, Compound I 2-amino-6-propionyl amine-4,5,6,7-tetrahydro benzothiazol add in reaction flask, then add methyl alcohol, add sodium methylate under stirring, are heated to backflow, are then cooled to room temperature;
B, slowly drip dithioglycol, dropwise rear temperature control stirring and react 3 hours, then concentrating under reduced pressure solvent evaporated, add wherein methylene dichloride stir molten clear after, add purified water agitator treating, point water-yielding stratum, in methylene dichloride, add magnesium sulfate stir dry, filtering siccative, evaporated under reduced pressure methylene dichloride;
C, add dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to autoclave, add catalyzer, pressure 0.1mpa is kept with passing into hydrogen after nitrogen replacement, temperature control stirring reacts 3 hours, filtering reacting liquid, be evaporated to dry, add recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [amino-4, the 6-tetrahydrochysenes 1 of 3-(6S)-2-, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4,5,6,7-tetrahydrochysene 1,3-benzothiazole-2,6-diamines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410498904.1A CN105481792B (en) | 2014-09-25 | 2014-09-25 | A kind of Pramipexole impurity C synthetic method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410498904.1A CN105481792B (en) | 2014-09-25 | 2014-09-25 | A kind of Pramipexole impurity C synthetic method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105481792A true CN105481792A (en) | 2016-04-13 |
CN105481792B CN105481792B (en) | 2017-08-29 |
Family
ID=55669112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410498904.1A Active CN105481792B (en) | 2014-09-25 | 2014-09-25 | A kind of Pramipexole impurity C synthetic method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105481792B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749092A (en) * | 2017-01-06 | 2017-05-31 | 成都倍特药业有限公司 | A kind of synthetic method on Pramipexole impurity C |
CN108084113A (en) * | 2016-11-23 | 2018-05-29 | 江苏恒瑞医药股份有限公司 | A kind of preparation method of Pramipexole impurity |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012233A (en) * | 2012-12-26 | 2013-04-03 | 华润赛科药业有限责任公司 | Preparation method of N-(amino sulfo methyl)-5-oxo-1-propyl-2-pyrrolidine acetamide |
-
2014
- 2014-09-25 CN CN201410498904.1A patent/CN105481792B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012233A (en) * | 2012-12-26 | 2013-04-03 | 华润赛科药业有限责任公司 | Preparation method of N-(amino sulfo methyl)-5-oxo-1-propyl-2-pyrrolidine acetamide |
Non-Patent Citations (3)
Title |
---|
ALEXANDER H. SCHMIDT等: "In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling-Case study pramipexole", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 * |
左延君: "亲水相互作用色谱质谱联用法测定盐酸普拉克索中有关物质", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
陈佳: "盐酸普拉克索的合成与质量研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108084113A (en) * | 2016-11-23 | 2018-05-29 | 江苏恒瑞医药股份有限公司 | A kind of preparation method of Pramipexole impurity |
CN108084113B (en) * | 2016-11-23 | 2021-05-14 | 江苏恒瑞医药股份有限公司 | Preparation method of pramipexole impurity |
CN106749092A (en) * | 2017-01-06 | 2017-05-31 | 成都倍特药业有限公司 | A kind of synthetic method on Pramipexole impurity C |
CN106749092B (en) * | 2017-01-06 | 2019-06-04 | 成都倍特药业有限公司 | A kind of synthetic method about Pramipexole impurity C |
Also Published As
Publication number | Publication date |
---|---|
CN105481792B (en) | 2017-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103910679B (en) | The preparation method of the assorted Shandong of a kind of grace amine | |
CN104478670A (en) | Preparation method of 5-bromine-2-chlorine-4'-ethyoxyl diphenylmethane | |
CN103304512A (en) | Preparation method for febuxostat | |
CN103420891B (en) | The synthetic method of type II diabetes medicine glimepiride intermediate benzene sulfanilamide (SN) triphosgene | |
CN101870682B (en) | Preparation method of 4-methylthiazolaldehyde-5 | |
CN108558628A (en) | Benzoic preparation method | |
CN103086847B (en) | Preparation method of phloroglucinol | |
CN102816122A (en) | Preparation method of pyrimethanil | |
CN103880762B (en) | A kind of preparation method of 1,2,3-triazole compound | |
CN105481792A (en) | Synthetic method with respect to pramipexole impurity C | |
CN101665471B (en) | Preparation method of febuxostat intermediate | |
CN113214133B (en) | Synthesis method of melatonin | |
CN102372678A (en) | Feed additive quinocetone and preparation method thereof | |
CN104072565A (en) | High-yield simple preparation method of 17alpha-hydroxy progesterone | |
CN100537552C (en) | Method for preparing Repaglinide | |
CN104311507A (en) | Preparation method of (6S)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole | |
CN105218474B (en) | The synthetic method of (4R, 5R) 2 dichloromethyl 4,5 dihydro 5 (4 methylsulfonyl phenyl) 4 oxazole methanol | |
CN103319416B (en) | Novel veterinary drug triclabendazole sulfoxide and preparation method thereof | |
WO2020029720A1 (en) | Method for preparing 2-chloro-6-methylthiotoluene | |
CN103319417A (en) | Method for preparing triclabendazole sulfoxide | |
CN111116551B (en) | 1-azaspiro [5.5] undecane-3-ones and 1-azaspiro [5.5] undecane-3-ols | |
CN104311469B (en) | A kind of synthetic method of substituted indole-3-acetic acid | |
CN102702196B (en) | Method for synthesizing 3-methyl-7-diazaindene | |
CN105198838A (en) | Preparation method of repaglinide | |
CN105348285A (en) | Low-cost and high-yield adenine preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210113 Address after: 251200 east of zhaotu main canal, east of Chuangxin street, high tech Development Zone, Yucheng City, Dezhou City, Shandong Province Patentee after: Shandong Ailan Pharmaceutical Co.,Ltd. Address before: 251400 12 Taixing East Street, Jiyang County, Jinan City, Shandong Province Patentee before: SHANDONG BOYUAN PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |